期刊文献+

血清中盐酸曲马多的膜式固相萃取及GC/MS/SIM测定 被引量:2

Determination of Tramadol Hydrochloride in Serum Samples by Disk Solid Phase Extraction and Gas Chromatography-mass Spectrometry in Selected Ion Monitoring
下载PDF
导出
摘要 目的建立血清中盐酸曲马多的膜式固相萃取(SPE)气-质联用分析方法。方法1mL血清用2mL0.1mol/L磷酸盐缓冲液(pH6)稀释后,用含有C18和强酸型强阳离子交换基团的SPECC18AR/MP3固相萃取柱萃取,洗脱液为含2%氨水的乙酸乙酯;选择SKF525作为内标物,用GC/MS/SIM定量测定。结果在加标量为0.1、0.2和0.5μg/mL的血清样品中,盐酸曲马多的回收率分别为98.9%、92.5%和84.8%,5次测定的RSD分别为3.2%、8.7%和10.9%;线性范围为0.1~4μg/mL,多项式回归相关系数r2=0.9939;检出限为21ng/mL;同一根萃取柱,连续使用5次,没有出现堵塞和污染,回收率及RSD未见下降。结论本方法适合于法医毒物分析。 Objective Disk solid phase extraction (SPE )was assessed for tramadol hydrochloride from serum. Methods The SPE was performed with SPEC C18AR/MP3 Disk SPE cartridge, offering hydrophobic C18 and strong cation ionic exchange interactions for the analytes, before being added into extraction column, 1mL serum was diluted by 2 mL 0.1 mol/L phosphate buffer solution (pH 6) and the eluent was ethyl acetate containing 2% ammonia. Then SKF525 was added as internal standard into samples, which would be extracted simultaneously with analyte,quantitatively, determined by GC/MS/SIM. Results The extraction recovery of tramadol hydrochloride was 98.9%, 92.5% and 84.8% for serum samples with corresponding amounts of standard addition of 0.1 μg/mL, 0.2 μg/mL and 0.5 μg/mL. And RSD measured 5 times was 3.2%, 8.7% and 10.9% respectively. The linear range varied from 0.1 μg/mL to 4μg/mL. The multinomial regression correlation coefficient (r^2) equaled 0.9939, and the detection limit was 21 ng/mL. After the same extraction column was continuously used for 5 times, there was no jam, pollution and decline of recovery and RSD. Conclusion This method is suitable for forensic toxicological analysis.
出处 《法医学杂志》 CAS CSCD 2006年第6期428-430,共3页 Journal of Forensic Medicine
关键词 盐酸曲马多 DISK SPE GC/MS/SIM 法医毒物分析 tramadol hydrochloride disk SPE GC/MS/SIM forensic toxicological analysis
  • 相关文献

参考文献4

二级参考文献10

  • 1Moreton JE, Meisch RA, Stark K, et al. Ketamine self-administration by the rhesus monky [ J ]. J Pharm Exp Ther,1977, 203: 303 - 309.
  • 2封世珍 张继宗 赵敬真."摇头丸"贩毒案简介及成分分析[A].论文选编写组.第三届全国毒物分析学术交流会论文选[C].北京:中国人民公安大学出版社,2000.126-130.
  • 3Wieber J, Gugler R, Hengstmann JH, et al. Pharmcokinetics of ketamine in man [ J]. Anaesthesist, 1975, 24:260 - 263.
  • 4Stenberg P, Idvall J. Does Ketamine metabolite Ⅱ Exist in vivo? [J]. BritJAnes, 1981, 53: 778-778.
  • 5Moore KA, Sklerov J, Levine B, et al. Urine concentrations of ketamine and norketamine [ J ]. J Anal Toxicol,2001, 25 (7): 583-588.
  • 6Kochhar MM. The identification of ketamine and its metabolites in biological fluids by gas chromatography-mass spectrometry [J]. Clin Toxicol, 1977, 11 (2): 265-275.
  • 7Feng N, Vollenweider FX, Minder EI, et al. Development of a gas chromatography-mass spectrometry method for determination of ketamine in urine and its application to human samples [J]. Ther Drug Monit, 1995, 17 (1): 95 -100.
  • 8Huang ZP, Zang SY. Confirmation of amphetamine, methamphetamine, MDA, and MDMA in urine samples using disk solid-phase extraction and gas chromatography-mass spectrometry after immunoassay screening [ J ]. J Chromatogr B, 2003, 792 (2): 239-245.
  • 9de Zeeuw RA, Wijsbeek J, Franke JP. SPEC disk solidphase extraction for rapid broad-spectrum drug screening in u- rine [J]. J Anal Toxicol, 2000, 24 (2): 97 -101.
  • 10Ugland HG, Krogh M, Rasmussen KE. Aqueous alkylchloroformate derivatization and solid-phase microextraction: determination of amphetamines in urine by capillary gas chromatography [J]. J Chromatogr B, 1997, 701:29 -38.

共引文献15

同被引文献33

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部